Paper16650970
Characterisation of the onset and presenting clinical features of adult bronchiectasis.
King PT and 4 others. Respir Med, 2006. Cited by 183 papers, by iCite.
Cite this record
ConductScience Library. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Papers, record 16650970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16650970
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bronchiectasis | Major topic |
| Asthma | |
| Chronic Disease | |
| Cohort Studies | |
| Cough | |
| Cross-Sectional Studies | |
| Dyspnea | |
| Fatigue | |
| Female | |
| Humans | |
| IgG Deficiency | |
| Male | |
| Middle Aged | |
| Pneumonia | |
| Pulmonary Disease, Chronic Obstructive | |
| Respiratory Function Tests | |
| Respiratory Sounds | |
| Rhinitis | |
| Sinusitis | |
| Smoking | |
| Sputum |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05719597 | PEP Breathing Versus Incentive Spirometry on Dyspnea and Sputum Profile in Bronchiolectasis Patients | Background | ClinicalTrials.gov | |
| NCT06209047 | Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of Bronchiectasis | Results | ClinicalTrials.gov |
Cited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42155584 | Active Cycle of Breathing Technique Versus Oscillating Positive Expiratory Pressure Therapy Versus Exercise With Huffing During an Exacerbation of Bronchiectasis: A Randomised, Controlled Trial. | Respirology | 2026 | https://conductscience.org/library/papers/42155584 | PubMed |
| 42094231 | Validation of bronchial airway gene expression associated with bronchiectasis in nasal epithelium. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/42094231 | PubMed |
| 41881528 | Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app. | BMJ Open | 2026 | https://conductscience.org/library/papers/41881528 | PubMed |
| 41555409 | Effects of atorvastatin on inflammatory markers, lipid profile, liver enzymes, and pulmonary function in patients with lung diseases: a systematic review and meta-analysis of randomized controlled trials. | Eur J Med Res | 2026 | https://conductscience.org/library/papers/41555409 | PubMed |
| 41535950 | Integrated traditional Chinese medicine and Western medicine strategies for the treatment of bronchiectasis: a comprehensive review. | Chin Med | 2026 | https://conductscience.org/library/papers/41535950 | PubMed |
| 41474423 | Evaluating serum TNF α in relation to bronchiectasis severity: Insights from FACED and BSI scoring systems. | Lung India | 2026 | https://conductscience.org/library/papers/41474423 | PubMed |
| 40512220 | Respiratory symptoms associated with a new lobe-based bronchial scoring system in an urban Chinese low-dose CT screening population. | Eur Radiol | 2025 | https://conductscience.org/library/papers/40512220 | PubMed |
| 40040890 | Heart rate recovery after the 6-min walk test in people with bronchiectasis. | ERJ Open Res | 2025 | https://conductscience.org/library/papers/40040890 | PubMed |
| 40001409 | Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40001409 | PubMed |
| 39478731 | Characteristics of different pathogenic bacterial infections and their effects on prognosis in adult patients with bronchiectasis. | Exp Ther Med | 2024 | https://conductscience.org/library/papers/39478731 | PubMed |
| 39386750 | A comprehensive review of Mycoplasma pneumoniae infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39386750 | PubMed |
| 39145140 | Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/39145140 | PubMed |
| 39070447 | A Case of New-Onset Atrial Tachyarrhythmias With Apical Hypertrophic Cardiomyopathy and Bronchiectasis in a Very Elderly Patient: A Therapeutic Dilemma. | Cureus | 2024 | https://conductscience.org/library/papers/39070447 | PubMed |
| 38978557 | Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan. | ERJ Open Res | 2024 | https://conductscience.org/library/papers/38978557 | PubMed |
| 38921790 | Medical Causes of Hospitalisation among Patients with Bronchiectasis: A Nationwide Study in Japan. | Pathogens | 2024 | https://conductscience.org/library/papers/38921790 | PubMed |
| 38628883 | Effects of Probiotics on Clinical Manifestations of Bronchiectasis: A Randomized, Triple Blinded, Placebo-Controlled Clinical Trial. | Tanaffos | 2023 | https://conductscience.org/library/papers/38628883 | PubMed |
| 38499811 | Asymptomatic Dysphagia and Aspiration in Patients with Idiopathic Bronchiectasis. | Lung | 2024 | https://conductscience.org/library/papers/38499811 | PubMed |
| 38422338 | Clinical determinants of the modified incremental step test in adults with non-cystic fibrosis bronchiectasis. | J Bras Pneumol | 2024 | https://conductscience.org/library/papers/38422338 | PubMed |
| 38390464 | Cystic Fibrosis Carrier States Are Associated With More Severe Cases of Bronchiectasis. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/38390464 | PubMed |
| 37969279 | Cough in chronic lung disease: a state of the art review. | J Thorac Dis | 2023 | https://conductscience.org/library/papers/37969279 | PubMed |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| BUDESONIDE | CHEMBL1370 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1370 | ChEMBL |
| LEVOFLOXACIN | CHEMBL5315124 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL5315124 | ChEMBL |
| GENTAMICIN | CHEMBL6067485 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL6067485 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16650970
GET https://conductscience.org/api/papers/v1/16650970/cited_by?page=2